aCCI ‐ HBV ‐ ACLF : A Novel Predictive Model for Hepatitis B Virus‐Related Acute‐On‐Chronic Liver Failure
Alimentary Pharmacology & Therapeutics · 2025-01 · 61 (2) · 286-298
DOI: 10.1111/apt.18347 ↗At a glance
Journal article in Alimentary Pharmacology & Therapeutics, published online on 2024-10-25. Written by Xinyi Chen and 12 co-authors. Institution: State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative…. Major MEDLINE topics: Acute-On-Chronic Liver Failure. Cited 12 times so far (Crossref); 38 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Key Research and Development Project of Zhejiang Province, High-level personnel cultivating project of Zhejiang Province, Fundamental Research Funds for the Central Universities.
Abstract (original language)
Background
Early identification of hepatitis B virus‐related acute‐on‐chronic liver failure (HBV‐ACLF) holds crucial importance in guiding clinical management and reducing mortality. However, existing scoring systems often overlook patient's underlying clinical condition, which significantly impacts prognosis.
Aims
Use the age‐adjusted Charlson comorbidity index (aCCI) to evaluate the patient's complications to develop a more precise model for predicting transplant‐free mortality in HBV‐ACLF patients.
Methods
Nine hundred and six patients were included for investigation and were segregated into a training cohort and a temporal validation cohort according to the chronological order of admission in a ratio of 7:3. In the training cohort, univariate analysis, logistic regression analysis and LASSO regression analysis were used to construct a prognostic model and it was subsequently validated in a temporal validation cohort and an external validation cohort.
Results
We found total bilirubin, neutrophils, international normalised ratio and aCCI exhibited significant associations with 28‐day transplant‐free mortality and established a novel prognostic model, named aCCI‐HBV‐ACLF. The model demonstrated strong predictive performance, with area under the receiver operating characteristic curve (ROC) values of 0.859 for 28‐day mortality, 0.822 for 90‐day mortality. In the temporal validation cohort, aCCI‐HBV‐ACLF achieved area under the ROC values of 0.869 for 28‐day mortality and 0.850 for 90‐day mortality. In the external validation cohort, aCCI‐HBV‐ACLF had area under the ROC values of 0.868 for 28‐day mortality and 0.888 for 90‐day mortality.
Conclusions
This study proposes a new prognostic model, which achieved excellent predictive ability for 28−/90‐day transplant‐free mortality rates among patients with HBV‐ACLF.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases,…
- Department of Infectious Diseases, Zhejiang Provincial People's Hospital & People's Hospital Affiliated of Hangzhou Medical College, Hangzhou City, China.
- National Medical Center for Infectious Diseases, Hangzhou City, China.
- Department of Clinical Laboratory, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou City, China.
- Zhejiang Key Laboratory for Diagnosis and Treatment of Physic-Chemical and Aging-Related Injuries, Hangzhou City, China.
ORCID profiles: Haijun Huang, Jiong Yu, Lanjuan Li, Hongcui Cao
Funding
- Key Research and Development Project of Zhejiang Province
- High-level personnel cultivating project of Zhejiang Province
- Fundamental Research Funds for the Central Universities
Cite
APA
Chen, X., Gao, F., Pan, Q., Huang, C., Luo, R., Lu, X., Chen, X., Li, T., Huang, H., Wu, J., Yu, J., Li, L., & Cao, H. (2025). aCCI ‐ HBV ‐ ACLF : A Novel Predictive Model for Hepatitis B Virus‐Related Acute‐On‐Chronic Liver Failure. Alimentary Pharmacology & Therapeutics, 61(2), 286-298. https://doi.org/10.1111/apt.18347
Vancouver
Chen X, Gao F, Pan Q, Huang C, Luo R, Lu X, et al. aCCI ‐ HBV ‐ ACLF : A Novel Predictive Model for Hepatitis B Virus‐Related Acute‐On‐Chronic Liver Failure. Alimentary Pharmacology & Therapeutics. 2025;61(2):286-298. doi:10.1111/apt.18347
BibTeX
@article{Chen2025,
author = {Chen, Xinyi and Gao, Feiqiong and Pan, Qiaoling and Huang, Chenjie and Luo, Rui and Lu, Xiaoqing and Chen, Xiaoxiao and Li, Tan and Huang, Haijun and Wu, Jian and Yu, Jiong and Li, Lanjuan and Cao, Hongcui},
title = {aCCI ‐ HBV ‐ ACLF : A Novel Predictive Model for Hepatitis B Virus‐Related Acute‐On‐Chronic Liver Failure},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2025},
volume = {61},
number = {2},
pages = {286--298},
doi = {10.1111/apt.18347}
}
EUVIMED